DIN 02483912 — NAT-ERLOTINIB 25 MG
NAT-ERLOTINIB is a tablet of Erlotinib marketed by NATCO PHARMA (CANADA) INC. The full Erlotinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02483912
- Brand name
- NAT-ERLOTINIB
- Active ingredient
- Erlotinib
- Strength
- 25 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- NATCO PHARMA (CANADA) INC
- Health Canada status
- DORMANT
- Drug class
- Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (antineoplastic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Erlotinib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02461870 | APO-ERLOTINIB | 100 MG | TABLET | APOTEX INC | MARKETED |
| 02461889 | APO-ERLOTINIB | 150 MG | TABLET | APOTEX INC | MARKETED |
| 02461862 | APO-ERLOTINIB | 25 MG | TABLET | APOTEX INC | MARKETED |
| 02483920 | NAT-ERLOTINIB | 100 MG | TABLET | NATCO PHARMA (CANADA) INC | DORMANT |
| 02483939 | NAT-ERLOTINIB | 150 MG | TABLET | NATCO PHARMA (CANADA) INC | DORMANT |
| 02454386 | PMS-ERLOTINIB | 100 MG | TABLET | PHARMASCIENCE INC | DORMANT |
| 02454394 | PMS-ERLOTINIB | 150 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02377705 | TEVA-ERLOTINIB | 100 MG | TABLET | TEVA CANADA LIMITED | MARKETED |
| 02377713 | TEVA-ERLOTINIB | 150 MG | TABLET | TEVA CANADA LIMITED | MARKETED |
| 02377691 | TEVA-ERLOTINIB | 25 MG | TABLET | TEVA CANADA LIMITED | MARKETED |